Potassium Carbonate → N-(tert-butyl)-5-(4-(((2-methylthiazol-4-yl)methyl)amino)-5-phenylpyrrolo[2,1-f][1,2,4]triazin-2-yl)pyridine-3-sulfonamide

HRID 2170176ノート

反応式

HRID 2170176 の反応式
Cl[C:2]1[N:7]=[C:6]([NH:8][CH2:9][C:10]2[N:11]=[C:12]([CH3:15])[S:13][CH:14]=2)[C:5]2=[C:16]([C:19]3[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=3)[CH:17]=[CH:18][N:4]2[N:3]=1.[C:25]([NH:29][S:30]([C:33]1[CH:34]=[N:35][CH:36]=[C:37](B2OC(C)(C)C(C)(C)O2)[CH:38]=1)(=[O:32])=[O:31])([CH3:28])([CH3:27])[CH3:26].C([O-])([O-])=O.[K+].[K+]>O1CCOCC1.O.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2].C(Cl)Cl>[C:25]([NH:29][S:30]([C:33]1[CH:34]=[N:35][CH:36]=[C:37]([C:2]2[N:7]=[C:6]([NH:8][CH2:9][C:10]3[N:11]=[C:12]([CH3:15])[S:13][CH:14]=3)[C:5]3=[C:16]([C:19]4[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=4)[CH:17]=[CH:18][N:4]3[N:3]=2)[CH:38]=1)(=[O:32])=[O:31])([CH3:28])([CH3:26])[CH3:27]

参加物

7

反応物 3

HCID 11430Potassium CarbonateHCID 903863802-Chloro-N-((2-methylthiazol-4-yl)methyl)-5-phenylpyrrolo[2,1-f][1,2,4]triazin-4-amineHCID 90386425N-(tert-Butyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-sulfonamide

生成物 1

HCID 90386066N-(tert-butyl)-5-(4-(((2-methylthiazol-4-yl)methyl)amino)-5-phenylpyrrolo[2,1-f][1,2,4]triazin-2-yl)pyridine-3-sulfonamide収率 33.3%

試薬・触媒・溶媒 3

HCID 178418807HCID 178418807、化合物触媒HCID 962Water溶媒HCID 312751,4-Dioxane溶媒

反応条件

温度
110 °C

実験手順

2-Chloro-N-((2-methylthiazol-4-yl)methyl)-5-phenylpyrrolo[2,1-f][1,2,4]triazin-4-amine (0.300 g, 0.843 mmol) and N-(tert-butyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-sulfonamide (0.574 g, 1.69 mmol) were dissolved in dioxane (25 mL) and water (3 mL). To the reaction mixture was added K2CO3 (0.350 g, 2.53 mmol) and the reaction mixture was degassed with nitrogen for 15 minutes. PdCl2(dppf)-CH2Cl2 (69.0 mg, 0.0840 mmol) was added and the resulting reaction mixture degassed with nitrogen for 20 minutes then heated to reflux at 110° C. for 14 h. The reaction mixture was allowed to cool and concentrated under reduced pressure. The residue was diluted with CH2Cl2 (2×25 mL) and filtered through CELITE®. The filtrate was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by column chromatography using CombiFlash (REDISEP®, silica gel, 40 g, 25% EtOAc/hexanes) to afford N-(tert-butyl)-5-(4-(((2-methylthiazol-4-yl)methyl)amino)-5-phenylpyrrolo[2,1-f][1,2,4]triazin-2-yl)pyridine-3-sulfonamide (0.150 g, 28.0%). LCMS Condition B-82: retention time 2.35 min, [M+1]=534.2. 1H NMR (400 MHz, DMSO-d6) δ ppm 1.15 (s, 9H), 2.62 (m, 3H), 4.88 (d, J=4.8 Hz, 2H), 6.75 (t, J=5.2 Hz, 1H), 6.85 (d, J=2.8 Hz, 1H), 7.36 (s, 1H), 7.42-7.57 (m, 5H), 7.94-7.97 (m, 2H) 8.91 (dd, J=2.0 Hz, J=2.4 Hz, 1H), 9.06 (d, J=2.4 Hz, 1H), 9.57 (d, J=2.0 Hz, 1H).

後処理

  1. customthe reaction mixture was degassed with nitrogen for 15 minutes
  2. customthe resulting reaction mixture
  3. customdegassed with nitrogen for 20 minutes
  4. temperaturethen heated
  5. temperatureto cool
  6. concentrationconcentrated under reduced pressure
  7. additionThe residue was diluted with CH2Cl2 (2×25 mL)
  8. filtrationfiltered through CELITE®
  9. dry with materialThe filtrate was dried over anhydrous sodium sulfate
  10. filtrationfiltered
  11. concentrationconcentrated under reduced pressure
  12. customThe residue was purified by column chromatography

出典と根拠

ORDレコード
ord-8e81dcbeeb374e71bbb1fe901cb9bcf5
出典データセット
uspto-grants-2015_06
特許番号
US09050345B2

反応ノート

読み込み中…